VIKING GLOBAL INVESTORS LP 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:01 pm Sale |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
VIKING GLOBAL INVESTORS LP | 1,790,284 3.900% |
-573,778 (-24.27%) |
Filing |
| 2021-02-12 7:50 pm Sale |
2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
VIKING GLOBAL INVESTORS LP | 2,364,062 5.300% |
-277,778 (-10.51%) |
Filing |
| 2020-10-05 5:04 pm Purchase |
2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP |
VIKING GLOBAL INVESTORS LP | 2,641,840 6.100% |
2,641,840 (New Position) |
Filing |